Factors Associated with the Decline of Forced Expiratory Volume in One Second Among Patients with Chronic Obstructive Pulmonary Disease Ratchaburi Hospital
Keywords:
COPD, FEV1 decline, spirometerAbstract
Objective: The purpose is study factors associated with the Decline of forced expiratory volume in one second (FEV1) in patients with chronic obstructive pulmonary disease (COPD) in Ratchaburi Hospital.
Methods: This was a retrospective study. The relevant data were collected from medical records of patients diagnosed with COPD in Ratchaburi Hospital from January 1, 2016 to June 30, 2020 to identify factors associated with decrease of FEV1 using multiple regression analysis.
Results: Eighty-four patients were included, 84.5% were male the mean age was 66.7 years. The annual reduction of FEV1 was 115.8 ml. after multiple regression analysis, the degree of smoking in the past, current cigarette smoker and the severity of COPD were related to the more reduction of FEV1. Of all factors, current cigarette smoking was the most important.
Conclusion: The current cigarette smoking is the most important factor related to reduction of FEV1 in patients with COPD. So cessation of smoking is advised in all COPD patients.
References
2. Lopez AD, Mathers CD, Ezzati M, et al. Global Burden of Disease and Risk Factors. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2006.
3. Maranetra KN, Chuaychoo B, Dejsomritrutai W, et al. The prevalence and incidence of COPD among urban older persons of Bangkok Metropolis. J Med Assoc Thai. 2002;85(11):1147-55.
4. กลุ่มรายงานมาตรฐาน คลังข้อมูลสุขภาพ Health Data Center กระทรวงสาธารณสุข. [cited 2021 Oct 27]. Available from: https://hdcservice.moph.go.th/hdc/main/index.php
5. Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ 1977;1(6077):1645–8.
6. Vestbo J, Edwards LD, Scanlon PD, et al. Changes in Forced Expiratory Volume in 1 Second over Time in COPD. N Engl J Med 2011;365(13):1184–92.
7. Sun Y, Milne S, Jaw JE, et al. BMI is associated with FEV1 decline in chronic obstructive pulmonary disease: a meta-analysis of clinical trials. Respir Res 2019;20(1):236.
8. Chen S, Wang C, Li B, et al. Risk factors for FEV1 decline in mild COPD and high-risk populations. COPD 2017;12:435–42.
9. Makris D, Moschandreas J, Damianaki A, et al. Exacerbations and lung function decline in COPD: New insights in current and ex-smokers. Respiratory Medicine 2007;101(6):1305–12.
10. Whittaker HR, Jarvis D, Sheikh MR, et al. Inhaled corticosteroids and FEV1 decline in chronic obstructive pulmonary disease: a systematic review. Respir Res 2019;20(1):277.
Downloads
Published
How to Cite
Issue
Section
License
ลิขสิทธิ์บทความเป็นของผู้เขียนบทความ แต่หากผลงานของท่านได้รับการพิจารณาตีพิมพ์ลงวารสารแพทย์เขต 4-5 จะคงไว้ซึ่งสิทธิ์ในการตีพิมพ์ครั้งแรกด้วยเหตุที่บทความจะปรากฎในวารสารที่เข้าถึงได้ จึงอนุญาตให้นำบทความในวารสารไปใช้ประโยชน์ได้ในเชิงวิชาการโดยจำเป็นต้องมีการอ้างอิงถึงชื่อวารสารอย่างถูกต้อง แต่ไม่อนุญาตให้นำไปใช้ในเชิงพาณิชย์
